Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Femke van Wijk

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Rheumatology (Oxford, England)|May 15, 2025
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacySaskia R Veldkamp, Maud Reugebrink, Sanne W Evers, et al.
Arthritis and Rheumatism|October 31, 2009
Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trialEva C Koffeman, Mark Genovese, Diane Amox, et al.
European Journal of Immunology|December 9, 2020
Antigen-driven PD-1<sup>+</sup> TOX<sup>+</sup> BHLHE40<sup>+</sup> and PD-1<sup>+</sup> TOX<sup>+</sup> EOMES<sup>+</sup> T lymphocytes regulate juvenile idiopathic arthritis in situPatrick Maschmeyer, Gitta Anne Heinz, Christopher Mark Skopnik, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome - a prospective cohort studyLobke C M Hensen, Bianca M M Streng, Femke van Wijk, et al.
BMC Infectious Diseases|February 15, 2022
Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohortArthur H van Stigt, Katrien Oude Rengerink, Kitty W M Bloemenkamp, et al.
Microbiome|January 17, 2025
Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulationRoos-Marijn Berbers, Fernanda L Paganelli, Joris M van Montfrans, et al.
Rheumatology (Oxford, England)|August 19, 2020
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular riskJudith Wienke, Jorre S Mertens, Samuel Garcia, et al.
American Journal of Human Genetics|January 7, 2023
Bi-allelic variants in NAE1 cause intellectual disability, ischiopubic hypoplasia, stress-mediated lymphopenia and neurodegenerationIrena J J Muffels, Imre F Schene, Holger Rehmann, et al.
Rheumatology (Oxford, England)|October 17, 2025
IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodiesThomas R J Moreau, Vincent Bondet, Saskia R Veldkamp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2019
Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort ValidationJudith Wienke, Felicitas Bellutti Enders, Johan Lim, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Rheumatology (Oxford, England)|May 15, 2025
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacySaskia R Veldkamp, Maud Reugebrink, Sanne W Evers, et al.
Arthritis and Rheumatism|October 31, 2009
Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trialEva C Koffeman, Mark Genovese, Diane Amox, et al.
European Journal of Immunology|December 9, 2020
Antigen-driven PD-1<sup>+</sup> TOX<sup>+</sup> BHLHE40<sup>+</sup> and PD-1<sup>+</sup> TOX<sup>+</sup> EOMES<sup>+</sup> T lymphocytes regulate juvenile idiopathic arthritis in situPatrick Maschmeyer, Gitta Anne Heinz, Christopher Mark Skopnik, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome - a prospective cohort studyLobke C M Hensen, Bianca M M Streng, Femke van Wijk, et al.
BMC Infectious Diseases|February 15, 2022
Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohortArthur H van Stigt, Katrien Oude Rengerink, Kitty W M Bloemenkamp, et al.
Microbiome|January 17, 2025
Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulationRoos-Marijn Berbers, Fernanda L Paganelli, Joris M van Montfrans, et al.
Rheumatology (Oxford, England)|August 19, 2020
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular riskJudith Wienke, Jorre S Mertens, Samuel Garcia, et al.
American Journal of Human Genetics|January 7, 2023
Bi-allelic variants in NAE1 cause intellectual disability, ischiopubic hypoplasia, stress-mediated lymphopenia and neurodegenerationIrena J J Muffels, Imre F Schene, Holger Rehmann, et al.
Rheumatology (Oxford, England)|October 17, 2025
IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodiesThomas R J Moreau, Vincent Bondet, Saskia R Veldkamp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2019
Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort ValidationJudith Wienke, Felicitas Bellutti Enders, Johan Lim, et al.
Pageof 11